Prospective Characterization of Circulating Tumor Cell Kinetics in Patients With Oligometastatic Disease Receiving Definitive Intent Radiation Therapy.
Shivani SudMichael J PoellmannJacob HallXianming M TanTae Hee LeeJa Hye MyungAndrew Z WangSeungpyo HongDana L CaseyPublished in: JCO precision oncology (2023)
CTCs may serve as a biomarker for disease control in OMD and may predict disease progression before standard assessments for patients receiving diverse cancer-directed therapies.